Expression of multidrug resistance-related markers in primary neuroblastoma

Chinese Medical Journal

Volumn 117, Issue 9, 2004, Pages 1359-1363

  Lu, Qing Jie ^a   Dong, Fang ^a   Zhang, Jin Hua ^a   Li, Xiao Han ^a   Ma, Ying ^a   Jiang, Wei Guo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Lung resistance protein; Multidrug resistance; Multidrug resistance associated protein; Neuroblastoma; P glycoprotein

Indexed keywords

ANTHRACYCLINE; DACTINOMYCIN; DOXORUBICIN; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PEROXIDASE; STREPTAVIDIN; TERPENOID; VINCA ALKALOID; VINCRISTINE; RIBONUCLEOPROTEIN; TUMOR PROTEIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIDRUG RESISTANCE; NEUROBLASTOMA; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; CHEMISTRY; DRUG RESISTANCE; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEUROBLASTOMA; P-GLYCOPROTEIN; PROGNOSIS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 16544370295     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fichtner I, Paal K, Borgmann A, et al. Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias-correlation to the expression of multidrug resistance proteins. Anticancer Res 2003;23:2657-2664.
2. Kazaki A, Toi M, Nakayama K, et al. Expression of multidrug resistance-related transporters in human breast carcinoma. Jpn J Cancer Res 2001;92:452-458.
3. Goff BA, Ries JA, Els LP, et al. Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure. Gynecol Oncol 1998;70:378-385.
4. Arts HJ, Katsaros D, de Vries EG, et al. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clin Cancer Res 1999;5:2798-2805.
5. Filipits M, Malayeri R, Suchomel RW, et al. Expression of the multidrug resistance-associated protein (MRP1) in breast cancer. Anticancer Res 1999;19:5043-5049.
6. Jedlitschky G, Leier I, Buchholz U, et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994;54:4833-4836.
7. Laurencot CM, Scheffer GL, Scheper RJ, et al. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int J Cancer 1997;72:1021-1026.
8. Diestra JE, Condom E, Del Muro XG, et al. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications. J Urol 2003;170:1383-1387.
9. Bordow SB, Haber M, Madafiglio J, et al. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 1994;54:5036-5040.
10. Wang J, Liu XY, Jiang W, et al. Expression of LRP, MRP and MDR1 in non-small-cell lung cancer and its clinical significance. Chin J Oncol(Chin) 2000;22:304-307.
11. Haber M, Bordow SB, Haber PS, et al. The prognostic value of MDR1 gene expression in primary untreated neuroblastoma. Eur J Cancer 1997;33:2031-2036.
12. Bader P, Schilling F, Schlaud M, et al. Expression analysis of multidrug resistance associated genes in neuroblastomas. Oncol Rep 1999;6:1143-1146.
13. Yanagisawa T, Newman A, Coley H, et al. An effective chemosensitizer in neuroblastoma. Br J Cancer 1999;80:1190-1196.
14. Slovak ML, Ho JP, Cole SP, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res 1995;55:4214-4219.
15. Goto H, Keshelava N, Matthay KK, et al. Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors. Med Pediatr Oncol 2000;35:619-622.
16. Peaston AE, Gardaneh M, Franco AV, et al. MRP1 geneexpression level regulates the death and differentiation response of neuroblastoma cells. Br J Cancer 2001;85:1564-1571.
17. Kurowski C, Berthold F. Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells. Ann Oncol 1998;9:1009-1014.
18. Dhooge CR, De Moerloose BM, Benoit YC, et al. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma. Cancer 1997;80:1250-1257.